OLEMA PHARMACEUTICALS, INC. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/76cfd7ce-cb9f-401f-a70d-c489f7f512a9/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-162.5M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-107169 |
| FY 2024 | $-129.5M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-041204 |
| FY 2023 | $-96.7M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-029281 |
| FY 2022 | $-104.8M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003318 |
| FY 2021 | $-71.1M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002388 |
| FY 2020 | $-22.1M | 2020-01-01 – 2020-12-31 | evidence 0001558370-22-002388 |
| FY 2019 | $-4.3M | 2019-01-01 – 2019-12-31 | evidence 0001558370-22-002388 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).